Clinical, epidemiological and immunological study of patients coinfected with HIV and HTLV-1;Estudio epidemiologico, clinico e inmunologico de pacientes coinfectados con HIV y HTLV-1

Medicina

Volumn 64, Issue 5, 2004, Pages 413-418

  Scapellato, Pablo G ^a,b   Bottaro, Edgardo G ^a   Seoane, Maria B ^a   Rodriguez Brieschke, Maria T ^a   Scapellato, Jose L ^a   Dato, Adriana ^a   Vidal, Gabriela I ^a  

^a Hospital Santojanni Buenos Aires   (Argentina)

^b NONE   (Argentina)

Author keywords

AIDS; CD4; HIV; HTLV 1; Intravenous drug users; Prevalence; Substance abuse

Indexed keywords

CD4 ANTIGEN; HUMAN T CELL LEUKEMIA VIRUS ANTIBODY;

ADOLESCENT; ADULT; ANAMNESIS; ANTIBODY DETECTION; ARTICLE; CELL COUNT; CONTROLLED STUDY; DRUG ABUSE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN T CELL LEUKEMIA VIRUS; HUMAN T CELL LEUKEMIA VIRUS INFECTION; IMMUNOLOGY; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PREVALENCE; SEX DIFFERENCE; VIRUS LOAD; ARGENTINA; CD4 LYMPHOCYTE COUNT; COMPARATIVE STUDY; EPIDEMIOLOGY; MIDDLE AGED; PROSPECTIVE STUDY; RISK; VIROLOGY;

ADOLESCENT; ADULT; ARGENTINA; CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HTLV-I INFECTIONS; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PREVALENCE; PROSPECTIVE STUDIES; SEROEPIDEMIOLOGIC STUDIES; SEX FACTORS; VIRAL LOAD;

EID: 9744282716     PISSN: 00257680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Gallo RC, Poiesz BJ, Ruscetti FW. Regulation of human T-cell proliferation: T-cell growth factor and isolation of a new class of type-C retroviruses from human T-cells. Haematol Blood Transfus 1981; 26: 502-14.
2. Gessain A, Barin F, Vernant JC, et al. Antibodies to human T-lymphotropic virus type-1 in patients with tropical spastic paraparesis. Lancet 1985; 2: 407.
3. Poeisz BJ, Ruscetti WF, Gadzar AF. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T cell lymphoma. Proc Natl Acad Sci USA 1990; 77: 7415-9.
4. Gotuzo E. Risk of transfusion-transmitted human T-cell lymphotropic virus Type-I in Latin America. Int J Infect Dis 2000; 4: 59-61.
5. Zaninovic M, Zamora T, Tajima K. Origins of T-cell leukemia virus. Nature 1990; 344: 249.
6. Gutfraind Z, Blejer JL, Saguier MC, et al. Seroprevalence of HTLV-I/HTLV-II in blood donors in Buenos Aires (Argentina). Vox Sang 1994; 67: 408-9.
7. Del Pino N, Martínez Peralta L, Pampuro, S, Pimentel E, Libonatti O. HTLV-I/II seroprevalence and coinfection with other pathogens in blood donors in Buenos Aires. J Acquir Immune Defic Syndr 1994; 7: 206-7.
8. Biglione M, Pizarro M, Crespo O, et al. High prevalence of HTLV-I infection in argentinian blood donors: a new HTLV-I endemic area?. J Acquir Immune Defic Syndr Hum Retrovirol 1999; 20: 101-2.
9. Medeot S, Nates S, Gallego S, et al. HTLV-I/II seropositivity in populations at high risk for HIV-1 infection in Cordoba city, Argentina. J Acquir Immune Defic Syndr. 1998; 18: 187-8.
10. Hakim A, Dunaiewsky A, Paganini A. HIV and HTLV-I prevalence among pregnant women in Buenos Aires, Argentina [abstract 297]. Clin Infect Dis 1998; 27: 976.
11. Gotuzzo E, Arango C, de Queiroz Campos A. Human T-cell lymphotropic virus-I in Latin America. Inf Dis Clin NA 2000; 14: 211-39.
12. de Araujo AC, Casseb JS, Neitzert E, et al. Prevalence and risk factors of HTLV-I and HTLV-II among HIV-1 infected patients in São Paulo, Brazil. Eur J Epidemiol 1994; 10: 1-6.
13. Galvão Castro B. Investigação laboratorial da infecção pelo HTLV-I/II e freqüência da infecção com o HIV. Rev Soc Bras Med Trop 1994; 27: 472-7.
14. Libonatti O, Lombardi V, Boxaca M, et al. Prevalencia de anticuerpos anti-HTLV-I en adictos a drogas por vía endovenosa en la Argentina. Medicina (Buenos Aires) 1989; 49: 546-7.
15. Harrison LH, Vaz B, Taveira DM, et al. Myelopathy among brazilians coinfected with human T-cell lymphotropic virus type 1 and HIV. Neurology 1997; 48: 13-8.
16. Cesaire R, Dehee A, Lezin A, et al. Quantification of HTLV-1 type-I and HIV type-I DNA load in coinfected patients: HIV type-I does not alter HTLV-1 proviral amount in the peripheral blood compartment. AIDS Res Hum Retroviruses 2001; 17: 799-805.
17. Bartholomew C, Blattner WA, Cleghorn F. Progression to AIDS in homosexual men co-infected with HIV and HTLV-I in Trinidad. Lancet 1987; 2: 1469.
18. Brites C, Harrington W Jr, Pedroso C, Martins Netto E, Badaro R. Epidemiological characteristics of HTLV-I and II coinfection in Brazilian subjects infected by HIV-1. Braz J Infect Dis 1997; 1: 42-7.
19. Sobesky M, Couppie P, Pradinaud R, et al. Coinfection with HIV and HTLV-I infection and survival in AIDS stage. French Guiana Study. Presse Med 2000; 29: 413-6.
20. Fantry L, De Jonge E, Auwaerter P, Lederman HM. Immunodeficiency and elevated CD4 T lymphocyte counts in two patients coinfected with human immunodeficiency virus and human lymphotropic virus type I. Clin Infect Dis 1995; 21: 1466-8.
21. Schechter M, Harrison LH, Halsey NA, et. al. Co-infection with human T-cell lymphotropic virus type I and HIV in Brazil: impact on markers of HIV disease progression. JAMA 1994; 271: 353-7.
22. Hovette P, Tuan JF, Camara P, et al. Pulmonary strongyloidiasis complicated by Escherichia coli meningitis in an HIV-I and HTLV-I positive patient. Presse Med. 2002; 31: 1021-3.
23. Nadler JP, Bach MC, Godofsky E. Management of coinfection with human immunodeficiency virus and human T-cell lymphotropic virus type I. Clin Infect Dis 1996; 23: 415.
24. Brites C, Pedroso C, Neto E, et al. Co-infection by HTLV-I/II is associated with increased viral load in PBMC of HIV-1 infected patients in Bahia, Brazil. Braz J Inf Dis 1998; 2: 70-7.
25. Schechter M, Moulton LH, Harrison LH. HIV viral load and CD4+ lymphocyte counts in subjects co-infected with HTLV-I and HIV-1. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 15: 308-11.
26. Brites C, Alencar R, Gusmao R, et al. Co-infection with HTLV-I is associated with a shorter survival time for HIV-I infected patients in Bahia, Brazil. AIDS 2001; 15: 2053-5.
27. Pagliuca A, Mufti GJ. Co-infection with HTLV-I/II and HIV-1. Lancet 1990; 336: 383.
28. Harrison LH, Quinn TC, Schechter M. Human T cell lymphotropic virus type I does not increase human immunodeficiency virus viral load in vivo. J Infect Dis 1997; 175: 438-40.